NeuroSense Therapeutics
Dr. Ferenc Tracik will serve as our chief medical officer starting December 1, 2021. Dr. Tracik has twenty years of experience in general management, medical affairs, clinical development, and commercialization in the biotech industry.
Before joining the Company, he served as the Global Head Medical of Orphazyme A/S. From May 2017 until November 2020, Dr. Tracik served as VP Medical Europe, Canada, and Partner Markets of Biogen Inc. From November 2013 until April 2017, Dr. Tracik served in various positions at Teva Pharmaceutical Industries Limited, including Managing Director Specialty Medicines Germany.
Dr. Tracik’s experience and expertise in therapy is extensive, and includes different disease areas such as CNS, respiratory, oncology, ophthalmology, infectious diseases, and transplantation), with a specific focus on neurodegenerative and neuro-autoimmune diseases. Before joining the pharmaceutical industry Dr. Tracik worked at the university clinics of neurology at Charité Berlin and the university clinic of Innsbruck.
He holds an MD from the Free University of Berlin.
This person is not in any offices
NeuroSense Therapeutics
NeuroSense Therapeutics is a clinical stage drug development company focusing on the development of a ground-breaking treatment for ALS patients, as well as other neurodegenerative diseases.